Christine M. Lovly MD, PhD

Christine M. Lovly, MD, PhD is currently an Associate Professor of Medicine with tenure at the Vanderbilt University Medical Center and Vanderbilt Ingram Cancer Center. She received a B.A. in chemistry from Johns Hopkins University followed by M.D. and Ph.D. degrees as part of the Medical Scientist Training Program at Washington University in St. Louis, MO. She then completed internal medicine residency and medical oncology subspecialty training at Vanderbilt University. During her final year of fellowship, she was the Jim and Carol O'Hare Chief Fellow. She started on faculty at Vanderbilt in July 2013 as a physician-scientist, splitting her time between clinical care and laboratory research. Her laboratory research is directed at understanding and developing improved therapeutic strategies for specific clinically relevant molecular subsets of lung cancer. 

Dr. Lovly has received grant funding from NIH/NCI, the Conquer Cancer Foundation of the American Society of Clinical Oncology, the American Cancer Society, the Damon Runyon Foundation, the LUNGevity Foundation, the V Foundation, the American Association for Cancer Research, and Lung Cancer Foundation of America / International Association for the Study of Lung Cancer. She is an active member in the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (IASLC), and the American Association for Cancer Research (AACR). 

Dr. Lovly is an elected member of the American Society for Clinical Investigation (ASCI) and a member of the Editorial Board for Cancer Discovery and JCO Precision Oncology. She serves on the Scientific Leadership Boards for the GO2 Foundation for Lung Cancer Research (where she also serves as SLB director), the LUNGevity Foundation, and the Lung Cancer Research Foundation. Dr. Lovly is a member of the AACR Science Policy and Government Affairs committee, co-chair of the Tobacco Products and Cancer subcommittee, and an elected member of the AACR Board of Directors. She serves on the NCCN guidelines panel for Non-Small Cell Lung Cancer and is co-chair of the ECOG-ACRIN Lung Biology Committee. 

In 2021, Dr. Lovly was awarded the ECOG-ACRIN Young Investigator Award. In 2022, she received the GO2 Foundation Asclepios Award honoring research pioneers in the fight to end lung cancer. In 2022, she also received Women Leaders in Oncology Recognition for exemplifying leadership in oncology and serving as a mentor and advocate.